Jangdeok Nokyong Research Institute - Iworld Pharmaceutical Affiliated Research Institute Sign Technology Agreement for Joint Development of Health Foods

Jangdeok Nokyong Research Institute announced on the 29th that it has signed a technology patent sharing agreement with IWorld Pharmaceutical's affiliated research institute, a company specializing in the development of natural herbal medicine-based pharmaceuticals, to jointly develop health foods.

I-World Pharmaceutical Research Institute and Jangdeok Nokyong Research Institute signed a technology patent sharing agreement on the 29th for the joint development of health supplements.
[Photo by Jangdeok Nokyong Research Institute]

Through this agreement, both companies have agreed to combine their efforts to develop new drugs, health functional improvement foods, general health processed foods, and other specialized products based on the technology patents for natural herbal substance extraction held by each company.

The technology patents that IWorld Pharmaceutical's affiliated research institute will share with Jangdeok Nokyong Research Institute total six types. These include three patents for herbal extracts that promote growth hormone secretion, two patents for fermented kudzu root extracts that help prevent osteoporosis, obesity, or hyperlipidemia, and other composition patents that aid in the prevention of thrombotic diseases.

Jangdeok Nokyong Research Institute is a health food company established by Shin Gwangsoon, director of Jangdeok Korean Medicine Hospital, well known for immune cancer treatment and frozen shoulder therapy, along with ten Korean medicine doctors affiliated with the hospital. Based on the accumulated clinical experience and herbal prescription know-how of the Korean medicine doctors, the company has attracted attention by consecutively launching liquid pouches and agarwood pills using Russian deer antler as the main ingredient.

Jeon Gwangseok, CEO of IWorld Pharmaceutical's affiliated research institute, said, "It is meaningful that our company's growth hormone secretion extract and osteoporosis prevention extract can be upgraded to a new level through collaboration with a health food company established by a prestigious Korean medicine hospital." Shin Gyeongae, CEO of Jangdeok Nokyong Research Institute, expressed expectations, saying, "Through this patent technology sharing agreement, we will be able to develop high value-added new products."

This content was produced with the assistance of AI translation services.